Zydus Lifesciences Ltd.

NSE: ZYDUSLIFE | BSE: 532321 | ISIN: INE010B01027 | Industry: Pharmaceuticals
| Mid-range Performer
975.0000 -44.25 (-4.34%)
NSE Sep 26, 2025 15:52 PM
Volume: 2.6M
High volume today

975.00
-4.34%
Karvy
Cadila's revenues grew by 22% YoY to Rs 25 bn (our estimate of Rs 24.2 bn) during the quarter on the back of strong performance in US region. Operating margins improved to 24.8% compared to 18.3% in Q1FY15, higher than our estimates of 21.5% due to better gross margins, lower staff cost and higher other operating income. Net Profit at Rs 3,534 mn in Q1FY16 grew by 47.1% YoY as compared to our estimate of Rs 3,399 mn.
Zydus Lifesciences Ltd.'s price crossed below 50Day SMA today
More from Zydus Lifesciences Ltd.
Recommended